MicroCHIPS Hires Industry Veteran Robert Farra to Lead Diabetes and Drug Delivery Product Programs.Company further strengthens glucose monitoring program with two key development hires BEDFORD, Mass. -- MicroCHIPS, Inc., an innovative developer of biosensing and drug delivery devices, today announced Robert Farra has joined the company as Vice President of Research and Development. Mr. Farra is charged with leading the company's drug delivery and diabetes monitoring programs through preclinical and clinical development. Bringing additional experience in glucose monitoring to MicroCHIPS are recent hires Kerstin Rebrin, MD, PhD and Yanan Zhang, PhD. MicroCHIPS is pioneering the next generation of implantable biosensing and drug delivery devices designed to increase therapeutic control, reduce painful interventions and improve health for people with diabetes, osteoporosis and other debilitating de·bil·i·tat·ing adj. Causing a loss of strength or energy. Debilitating Weakening, or reducing the strength of. Mentioned in: Stress Reduction diseases. "Bob Farra brings valuable experience directing technical teams in developing sophisticated medical devices," said John Santini, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , MicroCHIPS. "His leadership will help transform ground-breaking science supported by successful preclinical trials into revolutionary medical products." Mr. Farra joined MicroCHIPS from Abiomed, where he served as Vice President of Engineering and Manufacturing and led the development of several new products, including its implantable intra-aortic balloon and the iPulse[TM] control console. He successfully took both products through FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. and CE Mark approvals and oversaw manufacturing scale-up efforts in the US and Europe. Mr. Farra was also responsible for the design and manufacturing of Abiomed's left ventricular assist device left ventricular assist device Cardiology A mechanical device to ↑ force and volume of blood flowing through the heart. Cf CABG, Jarvik-7. and whole heart replacement products. Prior to Abiomed, Mr. Farra held leadership positions at Accellent Endoscopy and Arthur D. Little Arthur D. Little, Inc. is the world's first management consulting firm. Founded in 1886 by Arthur Dehon Little, an MIT chemist who discovered acetate, and co-worker Roger Griffin, in Cambridge, Massachusetts, Arthur D. Little pioneered the concept of contracted technology research. where he managed multidisciplinary device development teams for industry-leading companies in a wide range of clinical areas. Mr. Farra earned a BSME BSME Bachelor of Science in Mechanical Engineering BSME British Schools of the Middle East (UK) BSME Business Systems Modernization Executive BSME Breeder Reactor Structural Materials (Irradiation) Experiment from the University of Massachusetts The system includes UMass Amherst, UMass Boston, UMass Dartmouth (affiliated with Cape Cod Community College), UMass Lowell, and the UMass Medical School. It also has an online school called UMassOnline. , Lowell and an SMME SMME Small, Medium and Micro Enterprise SMME Solid Mechanics and Materials Engineering SMME Sisters of Mary, Mother of the Eucharist (Ann Arbor, MI) from the Massachusetts Institute of Technology Massachusetts Institute of Technology, at Cambridge; coeducational; chartered 1861, opened 1865 in Boston, moved 1916. It has long been recognized as an outstanding technological institute and its Sloan School of Management has notable programs in business, . "I'm delighted to join MicroCHIPS at this exciting point in the company's progress," said Robert Farra, vice president R&D, MicroCHIPS. "I look forward to working with the outstanding team at MicroCHIPS to create devices to improve the lives of millions of patients with diabetes and other chronic conditions." MicroCHIPS has further strengthened its development program with the addition of two diabetes experts, Kerstin Rebrin, MD, PhD and Yanan Zhang, PhD. Dr. Rebrin brings a wealth of diabetes experience to MicroCHIPS in her role as Senior Director of Preclinical and Clinical Research. Dr. Rebrin comes to MicroCHIPS from Abbott Diabetes Care, where she was the Director of Systems Engineering/Diabetes Therapy. Prior to her role at Abbott, she directed the Closed-loop Insulin Delivery Program for Medtronic Diabetes. Dr. Rebrin trained at the Diabetes Institute Karlsburg, Germany, and received her doctoral degree from the Medical University of Lubeck. Yanan Zhang, PhD joins MicroCHIPS as the Director of Sensor Technology. Dr. Zhang brings a track record of successful glucose sensor development to the company, including technical leadership as a Senior Principal Engineer with Medtronic Diabetes. Dr. Zhang received his PhD in Bioanalytical Chemistry at the University of Kansas The University of Kansas (often referred to as KU or just Kansas) is an institution of higher learning in Lawrence, Kansas. The main campus resides atop Mount Oread. , where he studied under Professor George Wilson. About MicroCHIPS MicroCHIPS, Inc. is pioneering "smart" implantable devices to create sophisticated monitoring and therapy systems. Based on breakthrough micro-reservoir systems originally developed at the Massachusetts Institute of Technology, MicroCHIPS' patented technologies have the ability to revolutionize today's medical implants by adding unique monitoring and targeted therapeutic capabilities designed to improve patient care in chronic diseases. MicroCHIPS' devices under development are based on advances the company has made in the fields of microelectromechanical systems (MEMS (MicroElectroMechanical Systems) Tiny mechanical devices that are built onto semiconductor chips and are measured in micrometers. In the research labs since the 1980s, MEMS devices began to materialize as commercial products in the mid-1990s. ), implant technologies, drug formulation and chemical sensing. www.mchips.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion